Distinct effects of infliximab and intravenous pulse methylprednisolone on CRP, interleukin-6 and matrix metalloproteinase-3 serum titers in rheumatoid arthritis patients with active disease despite methotrexate. A prospective randomised comparative study.

Durez, Patrick;Toukap, AN;Lauwerys, Bernard;Manicourt, Daniel;Houssiau, Frédéric;et.al.
(2003) 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: ORLANDO (Florida) (23.October.2003)

Files

No attached file found for this publication.

Details

Authors
  • Durez, PatrickUCLouvain
    Author
  • Toukap, AN
    Author
  • Lauwerys, BernardUCLouvain
    Author
  • Manicourt, DanielUCLouvain
    Author
  • Westhovens, ReneUCLouvain
    Author
  • Houssiau, FrédéricUCLouvain
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Durez, P., Toukap, A., Lauwerys, B., Manicourt, D., Westhovens, R., & Houssiau, F. (2003). Distinct effects of infliximab and intravenous pulse methylprednisolone on CRP, interleukin-6 and matrix metalloproteinase-3 serum titers in rheumatoid arthritis patients with active disease despite methotrexate. A prospective randomised comparative study. Arthritis & Rheumatism, 48(9), S124-S124. https://hdl.handle.net/2078.5/141424 (Original work published 2003)